24 pending office actions • 4 clients
| Client (Assignee) | Pending OAs |
|---|---|
| DANA-FARBER CANCER INSTITUTE, INC. | 20 |
| Cornell University | 2 |
| Korea Institute Of Science And Technology (Kist) | 1 |
| Neomorph, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18695529 | BINDERS OF CEREBLON AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | COUGHLIN, MATTHEW P | 1626 | Non-Final OA | Mar 26, 2024 |
| 18691268 | ERK5 DEGRADERS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | VAJDA, KRISTIN ANN | 1622 | Non-Final OA | Mar 12, 2024 |
| 18580469 | SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2) | DANA-FARBER CANCER INSTITUTE, INC. | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Jan 18, 2024 |
| 18577531 | SMALL MOLECULE CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) AND IKZF2 (HELIOS) DEGRADERS AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | LEESER, ERICH A | 1622 | Non-Final OA | Jan 08, 2024 |
| 18572945 | BIFUNCTIONAL COMPOUNDS THAT DEGRADE ALK AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | COLEMAN, BRENDA LIBBY | 1624 | Non-Final OA | Dec 21, 2023 |
| 18567873 | SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT | DANA-FARBER CANCER INSTITUTE, INC. | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Dec 07, 2023 |
| 18559655 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | Cornell University | GAUGER, PAUL RANDALL | 1629 | Non-Final OA | Nov 08, 2023 |
| 18215286 | INHIBITORS OF TRIM33 AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. | ANDERSON, REBECCA L | 1626 | Non-Final OA | Jun 28, 2023 |
| 18269122 | SMALL MOLECULE DEGRADERS OF PHOSPHATIDYLINOSITOL-5-PHOSPHATE 4-KINASE TYPE 2 AND USES THEREOF | Cornell University | RAO, PADMAJA S | 1627 | Non-Final OA | Jun 22, 2023 |
| 18144534 | CYCLIN-DEPENDENT KINASE INHIBITORS AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. | HOWELL, THEODORE R | 1628 | Non-Final OA | May 08, 2023 |
| 18033872 | COMPOUNDS FOR TARGETED PROTEIN DEGRADATION OF KINASES | Korea Institute Of Science And Technology (Kist) | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | Final Rejection | Apr 26, 2023 |
| 18031077 | PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | Neomorph, Inc. | TOWNSLEY, SARA ELIZABETH | 1629 | Final Rejection | Apr 10, 2023 |
| 18001995 | PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF PROTEIN/PROTEIN-FUSIONS | DANA-FARBER CANCER INSTITUTE, INC. | PURDY, KYLE A | 1611 | Final Rejection | Dec 15, 2022 |
| 17926074 | PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. | LEE, CHIHYI NMN | 1628 | Non-Final OA | Nov 17, 2022 |
| 17801709 | POTENT AND SELECTIVE DEGRADERS OF ALK | DANA-FARBER CANCER INSTITUTE, INC. | HEITMEIER, KENDALL NICOLE | 1621 | Final Rejection | Aug 23, 2022 |
| 17774002 | SELECTIVE HISTONE DEACETYLASE (HDAC) DEGRADERS AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | GAUGER, PAUL RANDALL | 1629 | Final Rejection | May 03, 2022 |
| 17773992 | SELECTIVE DUAL HISTONE DEACETYLASE 6/8 (HDAC6/8) DEGRADERS AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | HIRAKIS, SOPHIA P | 1623 | Final Rejection | May 03, 2022 |
| 17772384 | SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. | HIRAKIS, SOPHIA P | 1623 | Final Rejection | Apr 27, 2022 |
| 17642495 | KDM INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | RZECZYCKI, PHILLIP MATTHEW | 1625 | Non-Final OA | Mar 11, 2022 |
| 17580190 | TUNABLE ENDOGENOUS PROTEIN DEGRADATION | DANA-FARBER CANCER INSTITUTE, INC. | LEONARD, ARTHUR S | 1631 | Final Rejection | Jan 20, 2022 |
| 17601605 | DEGRADERS OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) | DANA-FARBER CANCER INSTITUTE, INC. | BAUER, NICOLA MARIA | 1621 | Final Rejection | Oct 05, 2021 |
| 17419965 | SMALL MOLECULE DEGRADERS OF FKBP12 VIA RECRUITMENT OF VON HIPPEL-LINDAU E3 UBIQUITIN LIGASE (VHL) E3 UBIQUITIN LIGASE, AND USES IN dTAG SYSTEMS | DANA-FARBER CANCER INSTITUTE, INC. | YOO, SUN JAE | 1621 | Non-Final OA | Jun 30, 2021 |
| 17284250 | DEGRADERS OF WILD-TYPE AND MUTANT FORMS OF LRRK2 | DANA-FARBER CANCER INSTITUTE, INC. | LADD, CAROLYN LOUISE | 1622 | Non-Final OA | Apr 09, 2021 |
| 17265139 | HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | PECKHAM, RICHARD GRANT | 1627 | Final Rejection | Feb 01, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial